Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5% | 2,331,627 | 0 | 2,331,627 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 5% | 2,331,627 | 0 | 2,331,627 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 4.1% | 1,902,682 | 0 | 1,902,682 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 4.1% | 1,902,682 | 0 | 1,902,682 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.6% | 299,876 | 0 | 299,876 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.6% | 299,876 | 0 | 299,876 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 9.1% | 4,234,309 | 0 | 4,234,309 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 10% | 4,632,749 | 0 | 4,632,749 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 10% | 4,632,749 | 0 | 4,632,749 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 10% | 4,632,749 | 0 | 4,632,749 | /s/ Mark N. Lampert | Mark N. Lampert |